Congress demands answers on how fentanyl reaches teens via social media
H.R. 6259 — No Fentanyl on Social Media Act · Filed by Gabe Evans (R-CO) · 8 cosponsors · Introduced Nov 21, 2025 · Markup held
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires the Federal Trade Commission, working with the FDA and DEA, to study and report within one year on how minors can buy fentanyl through social media platforms—including how drug sellers market it, what platform design features enable it, and what platforms are already doing to stop it. The report will be public and include recommendations for Congress to close these gaps.
Why we flagged it
The bill's core function is to mandate a fact-finding report on a specific public-health problem (youth fentanyl access via social media) and make findings public. It is not a regulatory or enforcement measure, but an information-gathering and disclosure requirement.
What the text implies
- Report findings may become the basis for future platform regulation or liability changes, creating indirect pressure on social media companies to self-regulate before Congress acts on recommendations.
- Redaction authority (for law enforcement tactics) creates a transparency gap—Congress and the public may not see the full scope of how drug sellers operate, limiting the utility of the report for public understanding.
The full analysis lists 4 implications of this text.
Who it affects
The bill creates transparency and accountability around a genuine public-health crisis (fentanyl overdose deaths among youth). It does not impose new restrictions on platforms or users—only requires fact-finding and public disclosure—making it a low-cost, high-information measure that serves the public interest without heavy-handed regulation.